hero-line-left hero-line-top
Product

The data foundation for enterprise precision medicine

Syapse software is built on a foundation of integrated clinical and molecular data, standardized across the network.

hero-line-bottom
hero-line-horizontal
temp-hero-icon

Connectivity with clinical databases, systems, and sources

Precision medicine requires centralized access to patient data that are typically siloed in electronic health records (EHRs), data warehouses, registries, and other systems. Syapse integrates patients’ clinical, pathology, radiology, treatment, lab results, and other information in a central data store to provide a single point of access.

Direct integration with molecular labs to capture structured molecular data

Today, genomic and other molecular test results are typically scanned into EHR systems and stored as unstructured data. Through direct integration with molecular diagnostics labs, Syapse enables healthcare systems to capture molecular profiles as structured data that can be used for decision support in the clinical workflow.

Common data standards across the network

Syapse standardizes and normalizes a robust set of data from multiple systems, allowing health systems to share data with other institutions, including patient demographics, cancer diagnoses, tumor genomics, tumor markers, treatments, and outcomes.

By harnessing our clinical and molecular data, and participating in data sharing through OPeN, we’ve experienced a positive halo effect as cancer care providers. The benefit of precision medicine is real and extends to our patients, administration, staff and communities.”
Lincoln Nadauld, MD
Lincoln Nadauld, MD
Executive Director of Precision Genomics, Intermountain Healthcare

In the news

Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs

5/2/19 - Precision medicine company Syapse has launched a collaboration with its one-time Big Pharma benefactor Amgen, with the goal of mining real-world evidence for insights into cancer drug development. Together, Amgen and Syapse will develop observational research analytics aimed at assessing outcomes in areas of unmet need—starting by identifying existing patients within Syapse’s health network that may be eligible for clinical trials, and then bringing those studies to nearby sites.

Read

Blog

Syapse Expands Security Posture with HITRUST Certification

Patient data collected from electronic health records, molecular testing and patient reported outcomes is powering many of the most exciting…

Read

Let’s talk

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.